Bioequivalence study between two formulations of ciclosporin A (Cyclavance® oral solution and Atopica® soft capsules) following a single oral administration to dogs

BACKGROUND: Ciclosporin is a selective immunomodulator used for the treatment of atopic dermatitis in dogs. A new 100 mg/ml oral solution formulation (Cyclavance®, Virbac) was developed as a pharmaceutical equivalent to the marketed capsule formulations (Atopica®, Novartis Animal Health) containing...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarro, C., Séguy, L., Vila, M., Birckel, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789266/
https://www.ncbi.nlm.nih.gov/pubmed/26970736
http://dx.doi.org/10.1186/s12917-016-0669-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789266/
https://www.ncbi.nlm.nih.gov/pubmed/26970736
http://dx.doi.org/10.1186/s12917-016-0669-9

Ejemplares similares